Point of Care (PoC) Diagnostics Market Growth rate and Industry Analysis to 2027

1. Point of Care (PoC) Diagnostics Market To Reach USD 50.51 Billion By 2026

2. Market Summary High number of diseases due to rise in geriatric population, product launches, increasing strategic developments such as partnerships and agreements, favourable research funding scenario for development of PoC testing devices are key factors contributing to high CAGR of Point of Care (PoC) Diagnostics during forecast period. Market Size – USD 23.98 Billion in 2018, Market Growth - CAGR of 9.6%. Market Trends – Product launches and research for Point of Care diagnostic products.

3. Our Approach Our Approach Market Summary According to the current analysis of Reports and Data, the global Point of Care (PoC) Diagnostics market was valued at USD 23.98 Billion in 2018 and is expected to reach USD 50.51 Billion by year 2026, at a CAGR of 9.6%. According to the Centers for Disease Control and Prevention (CDC), in US alone currently more than 100 million adults are living with diabetes or pre-diabetes. Cardiovascular diseases (CVD) account for approximately 800,000 deaths in the US. On average, one person dies from CVD every 40 seconds in the US. CVD also causes 3.9 million deaths in Europe and over 1.8 million deaths in the European Union. Point-of-care (POC) diagnostics or near-patient testing is a medical diagnostic test that allows physicians and medical staff to correctly attain real-time, lab-quality diagnostic results within minutes rather than hours. Through the use of portable blood analysers, testing at the “point of care” streamlines the diagnostic process and helps ensure patients receive the most effective and efficient care when and where it is needed. Point-of-care (POC) diagnostic testing permits staff to make speedy triage and treatment decisions when diagnosing a patient’s condition or monitoring a treatment response. By simplifying the testing process, clinicians can focus on what matters most—providing effective, quality patient care. Requestfor a sampleof this research report @ https://www.reportsanddata.com/sample-enquiry-form/1507

4. Our Approach Our Approach Market Summary Further key findings from the report suggest • Point of Care (PoC) Diagnostics market is fastest growing at a CAGR of 3% in Asia Pacific due to rising prevalence of strategic initiatives taken by international players to improve healthcare infrastructure and increasing awareness in developing countries like China and India • The market for Molecular diagnostics segment is projected to have the highest CAGR during the forecasted period because of the growing advancements in technology, increasing initiatives of market players for developing POC molecular diagnostics products, and resource-limited settings • Europe is the second largest region with a share of 33.1 % due to the increased adoption of advanced point of care diagnostic devices, rise in awareness about innovative and advanced applications of point of care diagnostic devices, and rapidly aging population coupled with increase in incidences of diabetes and liver diseases • Cardiometabolic Testing Products is accounted to be the second leading segment which is valued at USD 5411.7 million due to increasing number of patients with cardiac disorders and a huge demand and supply of cardiometabolic products across the regions To identify the key trends in the industry, click on the link below @ https://www.reportsanddata.com/report-detail/point-of-care-poc-diagnostics-market

5. Our Approach Our Approach Market Summary Key participants : Abbott, F. Hoffmann-La Roche and Siemens Healthineers. For the purpose of the study, this Reports and Data has segmented the Global Point of Care (PoC) Diagnostics Market on the basis of product type, platform type, prescription mode, end user and the regional outlook: Product Type (Revenue, USD Million; 2016–2026) Glucose Monitoring Products Strips Meters Lancets & Lancing Devices Cardiometabolic Testing Products Cardiac Marker Testing Products Blood Gas/Electrolytes Testing Products HBA1C Testing Products

6. Our Approach Our Approach Market Summary End User (Revenue, USD Million; 2016–2026) Professional Diagnostic Centres Clinical Laboratories (Outpatient Healthcare & Ambulatory Care Settings) Hospitals/Critical Care Centres Home Care Research Laboratories Other End Users Order Now@ https://www.reportsanddata.com/checkout-form/1507

7. About Us Our Approach Our Approach About Us About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com